Search

Your search keyword '"Passarelli O Jr"' showing total 4 results
Start Over Author "Passarelli O Jr"
4 results on '"Passarelli O Jr"'

1. I brazilian position paper on antihypertensive drug combination.

Author

Póvoa R, Barroso WS, Brandão AA, Jardim PC, Barroso O, Passarelli O Jr, Gemelli JR, Feitosa A, Jardim TV, Carneiro SB, Amodeo C, Moreira Filho O, Nogueira Ada R, Morais NS, Scala LC, Gonzaga C, Souza Ddo S, Paiva AM, Malachias MV, Mion D Jr, Mota-Gomes MA, Barbosa EC, Sousa MG, Bianco HT, Fonseca FA, Kalil M, Miranda RD, Uehara CA, and Sanjuliani AF

Subjects
Blood Pressure drug effects, Brazil, Cerebrovascular Disorders complications, Coronary Disease complications, Drug Therapy, Combination methods, Humans, Renal Insufficiency, Chronic drug therapy, Risk Factors, Treatment Outcome, Antihypertensive Agents administration & dosage, Hypertension drug therapy, Practice Guidelines as Topic, Societies, Medical
Published
2014
Full Text
View/download PDF

2. I Brazilian position statement on arterial hypertension and diabetes mellitus.

Author

Alessi A, Bonfim AV, Brandão AA, Feitosa A, Amodeo C, Alves CR, Brasil DP, Souza Ddo S, Barbosa E, Consolim-Colombo FM, Borelli F, Fonseca FH, Lopes HF, Chaves H, Bortolotto LA, Martin LC, Scala LC, Mota-Gomes MA, Malachias MV, Izar MC, Fonseca MI, Neves MF, Morais NS, Passarelli O Jr, Jardim PC, Toscano PR, Miranda RD, Franco R, Betti RT, Pedrosa RP, Povoa R, Carneiro SB, Jardim T, and Barroso WK

Subjects
Blood Glucose, Blood Pressure, Brain Diseases etiology, Brazil, Diabetes Complications therapy, Dyslipidemias drug therapy, Heart Diseases etiology, Humans, Hypertension therapy, Kidney Diseases etiology, Peripheral Arterial Disease etiology, Risk Factors, Societies, Medical, Diabetes Mellitus therapy, Hypertension complications
Published
2013
Full Text
View/download PDF

3. First Brazilian position on resistant hypertension.

Author

Alessi A, Brandão AA, Coca A, Cordeiro AC, Nogueira AR, Diógenes de Magalhães F, Amodeo C, Saad Rodrigues CI, Calhoun DA, Barbosa Coelho E, Pimenta E, Muxfeldt E, Consolin-Colombo FM, Salles G, Rosito G, Moreno H Jr, Martin JF, Yugar JC, Aparecido Bortolotto L, Nazário Scala LC, Gonçalves de Sousa M, Gomes MA, Malachias MB, Gus M, Passarelli O Jr, Jardim PC, Toscano PR, Sánchez RA, Dischinger Miranda R, Póvoa R, and Barroso WK

Subjects
Blood Pressure physiology, Blood Pressure Determination methods, Brazil, Drug Resistance physiology, Humans, Hypertension complications, Hypertension diagnosis, Hypertension physiopathology, Antihypertensive Agents therapeutic use, Hypertension drug therapy
Published
2012
Full Text
View/download PDF

4. Metabolic syndrome in patients undergoing coronary artery bypass graft: prevalence and a marker of morbidity/mortality during hospitalization and 30 days after hospital discharge.

Author

Pimenta E, Passarelli O Jr, Borelli F, Sousa MG, Gun C, Amato V, Amodeo C, and Piegas LS

Subjects
Coronary Artery Bypass adverse effects, Female, Humans, Length of Stay, Male, Metabolic Syndrome epidemiology, Middle Aged, Multivariate Analysis, Prevalence, Prospective Studies, Time Factors, Coronary Artery Bypass mortality, Metabolic Syndrome complications
Abstract

Objectives: To compare the morbidity and mortality of patients with and without metabolic syndrome (MS) (according to the First Brazilian Guidelines for Diagnosis and Treatment of MS) undergoing coronary artery bypass graft (CABG) during hospitalization and after 30 days., Methods: A total of 107 patients who underwent CABG with no associated procedures were assessed between August and October 2005; 74 (69.2%) of them had MS. Criteria of in-hospital outcome were: acute atrial fibrillation (AF), prolonged mechanical ventilation (MV), need for transfusion of blood products, number of hours spent in the ICU, length of hospital stay (days), respiratory and surgical wound infection, and death. For 30 days, the combination of events such as the need for readmission to hospital, surgical wound infection and death was assessed., Results: The mean age was 60.6 +/- 9.7 years, and the group with MS presented a higher body mass index and body surface, and a higher prevalence of diabetes. No statistically significant difference was observed in the occurrence of in-hospital events such as AF (15.2% vs. 16.2%), MV (3.0% vs. 2.7%), number of units of blood products used (3.2 +/- 2.7 vs. 2.6 +/- 2.9), length of ICU stay (53.7 +/- 27.3 vs. 58.9 +/- 56.5), length of hospital stay (9.2 +/- 8.7 x 8.5 +/- 8.5), respiratory infection (6.1% vs. 2.7%), surgical wound infection (3.0% vs. 5.4%), and mortality rate (3.0% vs. 0.0%). The occurrence of combined events in 30 days was similar in both groups (12.2% vs. 20.3%, p = NS)., Conclusion: Patients with MS did not have increased morbidity and mortality when undergoing CABG, however they had a higher trend of occurrence of surgical wound infection.

Published
2007
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results